Jupiter Life Line Hospitals Limited (NSE:JLHL)
India · Delayed Price · Currency is INR 285.65
-0.85 (-0.30%)
Nov 12, 2026, 3:30 PM IST
NSE:JLHL Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 93,645 | 84,003 | 104,679 | 78,450 | - | - | |
Market Cap Growth | -5.60% | -19.75% | 33.43% | - | - | - |
Enterprise Value | 96,018 | 82,480 | 101,387 | 75,249 | - | - |
Last Close Price | 286.80 | 256.04 | 318.85 | 238.78 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 50.22 | 43.30 | 54.18 | 44.42 | - | - |
Forward PE | 43.13 | 40.25 | 43.49 | 37.10 | - | - |
PS Ratio | 5.78 | 5.60 | 8.04 | 7.31 | - | - |
PB Ratio | 5.74 | 5.44 | 7.72 | 6.71 | - | - |
P/TBV Ratio | 5.80 | 5.47 | 7.74 | 6.72 | - | - |
P/FCF Ratio | - | - | - | 268.43 | - | - |
P/OCF Ratio | 34.20 | 31.38 | 39.24 | 68.50 | - | - |
PEG Ratio | 2.15 | 2.24 | 2.29 | 0.72 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.92 | 5.50 | 7.79 | 7.01 | - | - |
EV/EBITDA Ratio | 26.78 | 25.25 | 33.82 | 31.00 | - | - |
EV/EBIT Ratio | 36.91 | 32.10 | 41.02 | 37.49 | - | - |
EV/FCF Ratio | - | - | - | 257.47 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.41 | 0.38 | 0.29 | - | 1.29 | 1.72 |
Debt / EBITDA Ratio | 1.86 | 1.70 | 1.29 | - | 2.32 | 3.15 |
Debt / FCF Ratio | - | - | - | - | 11.74 | 10.95 |
Net Debt / Equity Ratio | 0.14 | 0.03 | -0.15 | -0.27 | 0.91 | 1.35 |
Net Debt / EBITDA Ratio | 0.69 | 0.13 | -0.69 | -1.31 | 1.65 | 2.48 |
Net Debt / FCF Ratio | -0.68 | -0.19 | 3.41 | -10.88 | 8.34 | 8.60 |
Asset Turnover | 0.71 | 0.70 | 0.81 | 0.95 | 0.94 | 0.87 |
Inventory Turnover | 19.89 | 17.81 | 21.27 | 19.94 | 19.31 | 20.57 |
Quick Ratio | 2.27 | 2.78 | 4.12 | 3.55 | 1.37 | 1.09 |
Current Ratio | 2.50 | 3.02 | 4.37 | 3.88 | 1.58 | 1.47 |
Return on Equity (ROE) | 12.11% | 13.39% | 15.35% | 23.05% | 22.35% | 19.12% |
Return on Assets (ROA) | 7.10% | 7.44% | 9.60% | 11.07% | 10.79% | 8.90% |
Return on Invested Capital (ROIC) | 11.24% | 14.00% | 18.38% | 23.45% | 13.49% | 12.15% |
Return on Capital Employed (ROCE) | 11.20% | 11.90% | 13.90% | 17.10% | 19.20% | 15.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.99% | 2.31% | 1.85% | 2.25% | - | - |
FCF Yield | -3.74% | -2.79% | -0.58% | 0.37% | - | - |
Dividend Yield | 0.07% | 0.08% | 0.06% | 0.08% | - | - |
Payout Ratio | 3.52% | 3.38% | 3.39% | 3.20% | 6.98% | - |
Buyback Yield / Dilution | 0.02% | - | -6.49% | -8.94% | -6.67% | -4.16% |
Total Shareholder Return | 0.09% | 0.08% | -6.43% | -8.86% | -6.67% | -4.16% |